MentionFox
Home › funding signals › Dorian Therapeutics
Accelerator · announced

Dorian Therapeutics (YC S18) — New therapeutics to rejuvenate tissue and treat age-related diseases

Dorian Therapeutics appears in Y Combinator's company directory in the Summer 2018 batch, listed 2018-05-28. New therapeutics to rejuvenate tissue and treat age-related diseases .

Just raised? Share it.

Dorian Therapeutics: Accepted into Y Combinator Summer 2018

What do you want to do with Dorian Therapeutics?

Dorian Therapeutics

New accelerator entry · 2018-05-28 · the record

Summer 2018
batch
8
people
Early
stage
United States of America
region
Open the record →

What the record says

BatchSummer 2018
Announced2018-05-28
StageEarly
StatusAcquired
Team size8
IndustryHealthcare
Sub-industryHealthcare -> Therapeutics
SectorsAnti-Aging, Biotech, Therapeutics
RegionsUnited States of America, America / Canada
BasedSan Francisco, CA, USA; San Carlos, CA, USA
HiringNo
Sitehttp://www.doriantherapeutics.com
Previously known asDorian therapeutics

The full profile

Checking your access…

Is this you?

If you're behind Dorian Therapeutics: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

Tools for this story

Each opens in a new tab, filled in for Dorian Therapeutics. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-dorian-therapeutics
Last updated 2026-09-26
Primary record: Y Combinator directory entry
Dorian Therapeutics (YC S18) — New therapeutics to rejuvenate tissue and treat age-related diseases. MentionFox, 2026-09-26. https://mentionfox.com/funding/yc-dorian-therapeutics